Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Times Interest Earned (2016 - 2017)

IGC Pharma (IGC) has disclosed Times Interest Earned for 8 consecutive years, with -$7.81 as the latest value for Q4 2017.

  • On a quarterly basis, Times Interest Earned rose 19.46% to -$7.81 in Q4 2017 year-over-year; TTM through Sep 2018 was -$3.09, a 63.3% increase, with the full-year FY2017 number at -$9.19, down 67.72% from a year prior.
  • Times Interest Earned was -$7.81 for Q4 2017 at IGC Pharma, down from -$6.44 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$0.94 in Q1 2016 to a low of -$26.53 in Q1 2014.
  • A 5-year average of -$9.11 and a median of -$7.71 in 2015 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: tumbled 1852.37% in 2014, then skyrocketed 95.95% in 2016.
  • IGC Pharma's Times Interest Earned stood at -$5.6 in 2013, then crashed by 43.86% to -$8.06 in 2014, then grew by 8.73% to -$7.35 in 2015, then crashed by 31.96% to -$9.7 in 2016, then rose by 19.46% to -$7.81 in 2017.
  • Per Business Quant, the three most recent readings for IGC's Times Interest Earned are -$7.81 (Q4 2017), -$6.44 (Q3 2017), and -$8.9 (Q2 2017).